论文部分内容阅读
通过对１２９例晚期胃癌化疗结果总结，证明文中报道的治疗晚期胃癌的三组化疗方案总疗效为３８．７％（５０／１２９），与文献报道的治疗晚期胃癌较好化疗方案有效率近似。三组化疗方案以ＭＦＡ（ＭＭＣ，５－Ｆｕ，ＡＤＭ）方案疗效稍高（且有两例完全缓解），有效率４４．１％（１５／３４）。ＤＶＭＦ（ＤＤＰ，ＶＣＲ，ＭＭＣ，５－Ｆｕ）方案和ＤＶＭ＋５－Ｆｕ衍生物（ＵＦＴ或ＦＴ－２０７或ＦｕｄＲ）方案有效率分别为４０．２％（２７／６７）和２８．６％（８／２８）。进一步分析治疗结果显示：化疗对贲门部癌较胃部癌疗效稍高，对术后复发转移病人的疗效较初治病人稍高，治疗胃腺癌的疗效较低分化腺癌的疗效稍高。
By summarizing the chemotherapy results of 129 cases of advanced gastric cancer, it was proved that the total efficacy of the three groups of chemotherapy regimens for treating advanced gastric cancer reported in the article was 38.7% (50/129), which was similar to the reported effective rate of chemotherapy for advanced gastric cancer. Three groups of chemotherapy regimens were slightly more effective (with two complete remissions) in the MFA (5-Fu, ADM) regimens, with an effective rate of 44.1% (15/34). The effective rates of DVMF (DDP, VCR, MMC, 5-Fu) and DVM+5-Fu derivatives (UFT or FT-207 or FudR) were 40.2% (27/67) and 28.6% (8/ 28). Further analysis of the treatment results showed that: Chemotherapy has a slightly higher response to gastric cardia cancer than gastric cancer. The efficacy of recurrent metastasis and metastasis is slightly higher than that of newly diagnosed patients. The efficacy of treatment of gastric adenocarcinoma is lower than that of adenocarcinoma.